Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Multiple micronutrient supplement (MMS) for pregnancy.
- Who it may be relevant to
- Registry conditions: Anemia, Pregnancy, Micronutrients, Supplement. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Cambodia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia: A Mixed-Methods Assessment
Overview
Malnutrition among pregnant women in low- and middle-income countries (LMICs) can cause micronutrient deficiencies that result in adverse maternal and neonatal health outcomes. The World Health Organization has recently recommended antenatal multiple micronutrient supplementation (MMS) that includes iron and folic acid (IFA) to improve maternal and neonatal health outcomes. MMS likely provides additional antenatal benefits over IFA supplementation alone. The Cambodian government, in partnership with Helen Keller International, is piloting MMS implementation in Takeo Province, which will inform nationwide scale-up of MMS. Study Purpose: The Takeo implementation must be evaluated to understand context-specific implementation of MMS and health system readiness for scale-up. This study assesses system readiness through four domains from the Intervention Scalability Assessment Tool (ISAT): (1) fidelity and adaptation, (2) reach and acceptability, (3) delivery setting and workforce capacity, and (4) implementation infrastructure. Population: The pilot involves transitioning to MMS from IFA across all 86 health centers, all 6 referral hospitals, and the provincial hospital in Takeo province. This study includes pregnant women receiving antenatal care, antenatal healthcare providers and facilities, and hospital managers in Takeo. The study also includes national governing bodies for MMS delivery. Methods: This mixed-methods study uses ISAT as a framework for developing data collection methods. Sampling strategies emphasize urban and rural representation across all operational districts in Takeo and diverse stakeholder perspectives at multiple levels of the health system. Data collection includes: * 12 focus group discussions (FGDs) with health center providers to assess provider adherence to MMS delivery guidelines, perspectives on the transition to MMS, and additional resources needed for MMS delivery * Workload assessment surveys at FGDs to quantify any burden on providers and resource gaps to deliver MMS * MMS stockout monitoring at 18 health centers and 7 hospitals to assess supply chain reliability * 15 key informant interviews with hospital managers to assess perspectives on the integration of MMS into antenatal services and facility readiness for MMS delivery * Phone surveys with 630 pregnant women to assess acceptability and adherence to MMS at 90- and 180-days after MMS distribution * One FGD with national-level stakeholders to assess national-level readiness, economic planning, and resource planning for sustainable MMS implementation and scale-up * Rapid economic evaluation to estimate the cost of nationwide scale-up Potential Impact: This study will generate insights into real-world implementation of MMS in Cambodia. It will identify context-specific adaptations, implementation gaps, and resource planning frameworks needed for nationwide scale-up of MMS. Successful scale-up is anticipated to improve maternal and neonatal health in Cambodia. Findings can also be used to guide other LMICs seeking to transition to and sustainably implement MMS.
Interventions
- Dietary supplement Multiple micronutrient supplement (MMS) for pregnancy
Standard of care MMS during pregnancy (180 tablets total)
Primary outcome measures
- Perspectives on the transition to MMS [Time frame: 4 months]
Secondary outcome measures (6)
- Additional resources needed for successful MMS delivery [Time frame: 4 months]
- Provider adherence to MMS delivery guidelines [Time frame: 4 months]
- Adherence of pregnant individuals to MMS supplementation [Time frame: 6 months]
- Perspectives on the integration of MMS into antenatal services and facility readiness for MMS delivery [Time frame: 4 months]
- National-level readiness, economic planning, and resource planning for sustainable MMS implementation and scale-up [Time frame: 4 months]
- Quantification of any burden on providers and resource gaps to deliver MMS [Time frame: 4 months]
Eligibility criteria
For the cohort of pregnant individuals consuming MMS:
Inclusion criteria
- Current pregnant
- At least 18 years of age
- Have attended at least one ANC visit at a health center or hospital in Takeo during the study period
- Can provide a functioning phone number for follow-up contact
- Willingness to participate and provide consent
Exclusion criteria
- Individuals with diagnosed anemia who require iron and folic acid (IFA) supplementation instead of MMS
- Individuals unable to communicate via telephone,;(3) individuals who withdraw consent at any point
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Cambodia · 1 center
- Takeo province — Phnom Penh
Identifiers
NCT: NCT07400796 · TIPSCambodia2026